Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Correction to: Breast Cancer https://doi.org/10.1007/s12282-021-01290-5
In the original publication of the article, the Table 2 was published incorrectly with missing values. The corrected Table 2 is given in this correction.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Taira, N., Kashiwabara, K., Tsurutani, J. et al. Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer. Breast Cancer 29, 186–188 (2022). https://doi.org/10.1007/s12282-021-01296-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-021-01296-z